- Less expensive.
- Less error-prone.
- Significantly easier to perform.
Genomic Prediction provides advanced genetic testing for IVF. We have developed a novel, genome-wide molecular genotyping methodology for pre-implantation genetic testing of embryos.
Our approach reduces disease risk and improves newborn health outcomes by identifying candidate embryos for implantation which are genetically normal.
(of human disease)
August 2018 Marks the CLIA application approval of Genomic Prediction's PGT-A (Preimplantation Genetic Test for Aneuploidy) test, in accord with the IVF medical standards of the New Jersey Department of Health.
Conformité Européenne (CE) marking of the gPGT-A platform and software for aneuploidy testing delineates an important milestone for Genomic Prediction's ⓖSEQ product, reflecting the quality and reliability of Genomic Prediction's technology.
"What should we do with mosaic embryos?" is the title of Chief Science Officer Dr. Nathan Treff's recent lecture, making the case for deep revisions of current practice.
Genomic Prediction is engaged in a number of academic collaborations across the world. Our first embryo research collaboration has completed a first phase, successfully genotyping and karyotyping research embryo biopsies.